1,303
Views
6
CrossRef citations to date
0
Altmetric
RSV

Respiratory syncytial virus-associated hospitalization in children aged <2 years in Spain from 2018 to 2021

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2231818 | Received 21 Mar 2023, Accepted 28 Jun 2023, Published online: 12 Jul 2023

References

  • Riccò M, Cerviere MP, Corrado S, Ranzieri S, Marchesi F. Respiratory syncytial virus: an uncommon cause of febrile seizures-results from a systematic review and meta-analysis. Pediatr Rep. 2022;14(4):464–9. doi:10.3390/pediatric14040055.
  • Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, Albertson SB, Deshpande A, Farag T, Abebe Z, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–210. doi:10.1016/S1473-3099(18)30310-4.
  • Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, Baraldi E, Papadopoulos NG, Nair H, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217:1356–64. doi:10.1093/infdis/jiy056.
  • Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, et al. RSV global epidemiology network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–58. doi:10.1016/S0140-6736(17)30938-8.
  • Hall CB. The burgeoning burden of respiratory syncytial virus among children. Infect Disord Drug Targets. 2012;12:92–7. doi:10.2174/187152612800100099.
  • Corsello G, Di Carlo P, Salsa L, Gabriele B, Meli L, Bruno S, Titone L. Respiratory syncytial virus infection in a Sicilian pediatric population: risk factors, epidemiology, and severity. Allergy Asthma Proc. 2008;29(2):205–10. doi:10.2500/aap.2008.29.3101.
  • Lanari M, Giovannini M, Giuffré L, Marini A, Rondini G, Rossi GE, Merolla R, Zuccotti GV, Salvioli GP. The investigators R.A.DA.R. study group. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol. 2002;33(6):458–65. doi:10.1002/ppul.10047.
  • Hervás D, Reina J, Yañez A, Del Valle JM, Figuerola J, Hervás JA. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis. 2012;31(8):1975–81. doi:10.1007/s10096-011-1529-y.
  • Respiratory Syncytial Virus Infection (RSV): Trends and Surveillance. Centers for disease control and prevention. [accessed 2023 Mar 13]. https://www.cdc.gov/rsv/research/us-surveillance.html.
  • Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Carbonell-Estrany X. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western Countries. Infect Dis Ther. 2016;5(3):271–98. doi:10.1007/s40121-016-0123-0.
  • European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA. 2022 Dec 12.
  • Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao H, Ellis J, Smith GE, Elliot AJ. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23(1):56–66. doi:10.1016/S1473-3099(22)00525-4.
  • Nivel. The GERI study. [accessed 2023 Jan 30]. https://www.nivel.nl/en/geri.
  • Juhn YJ, Wi CI, Takahashi PY, Ryu E, King KS, Hickman JA, Yao JD, Binnicker MJ, Natoli TL, Evans TK, et al. Incidence of respiratory syncytial virus infection in older adults before and during the COVID-19 pandemic. JAMA Netw Open. 2023;6(1):e2250634. doi:10.1001/jamanetworkopen.2022.50634.
  • Heppe-Montero M, Gil-Prieto R, Del Diego Salas J, Hernández-Barrera V, Gil-de-Miguel Á. Impact of respiratory syncytial virus and influenza virus infection in the adult population in Spain between 2012 and 2020. Int J Environ Res Public Health. 2022;19(22):14680. doi:10.3390/ijerph192214680.
  • Regassa BT, Gebrewold LA, Mekuria WT, Kassa NA. Molecular epidemiology of respiratory syncytial virus in children with acute respiratory illnesses in Africa: a systematic review and meta-analysis. J Glob Health. 2023;13:04001. doi:10.7189/jogh.13.04001.
  • Sitthikarnkha P, Uppala R, Niamsanit S, Sutra S, Thepsuthammarat K, Techasatian L, Niyomkarn W, Teeratakulpisarn J. Burden of respiratory syncytial virus related acute lower respiratory tract infection in hospitalized Thai children: a 6-year national data analysis. Children (Basel). 2022;91990(12). doi:10.3390/children9121990.
  • Heppe-Montero M, Walter S, Hernández-Barrera V, Gil-Prieto R, Gil-de-Miguel Á. Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infect Dis. 2022;22(1):315. doi:10.1186/s12879-022-07261-1.
  • Ihling CM, Schnitzler P, Heinrich N, Mangu C, Sudi L, Souares A, Gies S, Sié A, Coulibaly B, Ouédraogo AT, et al. Molecular epidemiology of respiratory syncytial virus in children in Sub-Saharan Africa. Trop Med Int Health. 2021;26(7):810–22. doi:10.1111/tmi.13573.
  • Buchwald AG, Tamboura B, Tennant SM, Haidara FC, Coulibaly F, Doumbia M, Diallo F, Keita AM, Sow SO, Kotloff KL, et al. Epidemiology, risk factors, and outcomes of respiratory syncytial virus infections in newborns in Bamako, Mali. Clin Infect Dis. 2020;70(1):59–66. doi:10.1093/cid/ciz157.
  • Gil-Prieto R, Gonzalez-Escalada A, Marín-García P, Gallardo-Pino C, Gil-de-Miguel A. Respiratory syncytial virus bronchiolitis in children up to 5 years of age in Spain: epidemiology and comorbidities: an observational study. Medicine. 2015;94(21):e831. doi:10.1097/MD.0000000000000831.
  • Hernández-Rivas L, Pedraz T, Calvo C, San Juan I, Mellado MJ, Robustillo A. Respiratory syncytial virus outbreak during the COVID-19 pandemic. How has it changed? Enferm Infecc Microbiol Clin. 2023;41(6):352–5. doi:10.1016/j.eimc.2021.12.003.
  • Halabi KC, Saiman L, Zachariah P. The epidemiology of respiratory syncytial virus in New York City during the coronavirus disease-2019 pandemic compared with previous years. J Pediatr. 2022;242:242–4.e1. doi:10.1016/j.jpeds.2021.10.057.
  • Tabor DE, Fernandes F, Langedijk AC, Wilkins D, Lebbink RJ, Tovchigrechko A, Ruzin A, Kragten-Tabatabaie L, Jin H, Esser MT, et al. Global molecular epidemiology of respiratory syncytial virus from the 2017-2018 INFORM-RSV study. J Clin Microbiol. 2020;59(1):e01828–20. doi:10.1128/JCM.01828-20.
  • Gonapaladeniya M, Dissanayake T, Liyanage G. Burden of respiratory syncytial virus associated severe pneumonia in hospitalized children. Int J Pediatr. 2021;2021:8269400. doi:10.1155/2021/8269400.
  • Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013;31(2):B209–215. doi:10.1016/j.vaccine.2012.11.106.
  • Noble M, Khan RA, Walker B, Bennett E, Gent N. Respiratory syncytial virus-associated hospitalisation in children aged =5 years: a scoping review of literature from 2009 to 2021. ERJ Open Res. 2022;8(2):00593–2021. doi:10.1183/23120541.00593-2021.
  • Xie Z, Qin Q, Shen K, Fang C, Li Y, Deng T. The burden of respiratory syncytial virus associated with acute lower respiratory tract infections in Chinese children: a meta-analysis. Transl Pediatr. 2020;9(4):496–506. doi:10.21037/tp-20-148.
  • Ministerio de Sanidad y Consumo. Clasificación Internacional de Enfermedades. 10ª Revisión, Modificación Clínica. 2018.
  • Instituto Nacional de la Salud. Subdirección General de Coordinación administrativa. Conjunto Mínimo Básico de Datos. Hospitales de INSALUD 2001. Madrid; 2002 [accessed 2023 Feb 6]. https://ingesa.sanidad.gob.es/bibliotecaPublicaciones/publicaciones/internet/docs/CMBD-2001.pdf.
  • Ministerio de Sanidad y Consumo. Agencia de Calidad del Sistema Nacional de Salud. Instituto de Información Sanitaria. Metodología de análisis de la hospitalización en el sistema nacional de salud. Modelo de indicadores basado en el registro de altas (CMBD). 2008 [accessed 2023 Feb 6]. https://www.sanidad.gob.es/en/estadEstudios/estadisticas/docs/metod_modelo_cmbd_pub.pdf.
  • Heppe Montero M, Gil-Prieto R, Walter S, Aleixandre Blanquer F, Gil De Miguel Á. Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017. Hum Vaccin Immunother. 2022;18(1):1883379. doi:10.1080/21645515.2021.1883379.
  • Okes DJ, Ngama M, Bett A, Abwao J, Munywoki P, English M, Scott J, Cane P, Medley G. Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis. 2009;49(9):1341–9. doi:10.1086/606055.
  • Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55. doi:10.1016/S0140-6736(10)60206-1.
  • Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J. 2012;31(1):5–9. doi:10.1097/INF.0b013e31822e68e6.
  • Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, Anderson LJ. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics. 2004;114(4):e437–444. doi:10.1542/peds.2004-0049.
  • Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, Steiner C, Abedi GR, Anderson LJ, Brammer L, Shay DK, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis. 2012;54(10):1427–36. doi:10.1093/cid/cis211.
  • Ajayi-Obe EK, Coen PG, Handa R, Hawrami K, Aitken C, McIntosh EDG, BOOY R. Influenza a and respiratory syncytial virus hospital burden in young children in East London. Epidemiol Infect. 2008;136(8):1046–58. doi:10.1017/S0950268807009557.
  • Svensson C, Berg K, Sigurs N, Trollfors B. Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections. Acta Paediatr. 2015;104(9):922–6. doi:10.1111/apa.13061.
  • Hacimustafaoglu M, Celebi S, Bozdemir SE, Ozgür T, Ozcan I, Güray A, Cakır D. RSV frequency in children below 2 years hospitalized for lower respiratory tract infections. Turk J Pediatr. 2013;55:130–9.
  • Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009;94(2):99–103. doi:10.1136/adc.2008.139188.
  • Luz García MA, Murua JK, Callejón Callejón A. Bronquiolitis aguda viral. AEP. 2017;1:85–102.
  • Zuccotti G, Dilillo D, Zappa A, Galli E, Amendola A, Martinelli M, Pariani E, Salvini F, Tanzi E, Riva E, et al. Epidemiological and clinical features of respiratory viral infections in hospitalized children during the circulation of influenza virus A(H1N1) 2009. Influenza Other Respir Viruses. 2011;5(6):e528–534. doi:10.1111/j.1750-2659.2011.00264.x.
  • Constantopoulos AG, Kafetzis DA, Syrogiannopoulos GA, Roilides EJ, Malaka-Zafiriu EE, Sbyrakis SS, Marcopoulos M. Burden of respiratory syncytial viral infections on paediatric hospitals: a two-year prospective epidemiological study. Eur J Clin Microbiol Infect Dis. 2002;21(2):102–7. doi:10.1007/s10096-001-0668-y.
  • Cattoir L, Vankeerberghen A, Boel A, Van Vaerenbergh K, De Beenhouwer H. Epidemiology of RSV and hMPV in Belgium: a 10-year follow-up. Acta Clin Belgica Int J Clin Lab Med. 2019;74(4):229–35. doi:10.1080/17843286.2018.1492509.
  • Alonso A, Andres JM, Garmendia JR, Diez I, Gil JM, Ardura J. Bronchiolitis due to respiratory syncytial virus in hospitalized children: a study of seasonal rhythm. Acta Paediatr. 2007;96:731–5. doi:10.1111/j.1651-2227.2007.00266.x.
  • Weigl JA, Puppe W, Rockahr S, Schmitt HJ. Burden of disease in hospitalized RSV-positive children in Germany. Klin Padiatr. 2002;214(6):334–42. doi:10.1055/s-2002-35365.
  • Brady MT, Byington CL, Davies HD, Edwards KM, Jackson MA, Maldonado YA, Murray DL, Orenstein WA, Rathore MH, Sawyer MH, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):415–20. doi:10.1542/peds.2014-1665.
  • Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98. doi:10.1056/NEJMoa0804877.
  • Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, et al. Respiratory syncytial virus–associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341–348. doi:10.1542/peds.2013-0303.
  • Vicente D, Montes M, Cilla G, Perez-Yarza EG, Perez-Trallero E. Hospitalization for respiratory syncytial virus in the paediatric population in Spain. Epidemiol Infect. 2003;131(2):867–72. doi:10.1017/s0950268803008926.
  • Sanchez-Luna M, Elola FJ, Fernandez-Perez C, Bernal JL, Lopez-Pineda A. Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012. Curr Med Res Opin. 2016;32(4):693–8. doi:10.1185/03007995.2015.1136606.